Publications by authors named "Keren Meir"
Article Synopsis
- Antiphospholipid syndrome patients often receive vitamin K antagonists, but only 29.9% achieve an optimal therapeutic range (INR ≥ 70%), which is linked to better outcomes.* -
- Those with three or more comorbidities are significantly less likely to reach this therapeutic range (9.1%) compared to those with fewer comorbidities (40%).* -
- Patients maintaining an INR ≥ 70% experience fewer recurrent thrombotic events, particularly arterial ones, highlighting the need for close monitoring in this population.*
Cancer is a complex disease that involves aberrant gene expression regulation. Discriminating the modified expression patterns driving tumor biology from the many that have no or little contribution is important for understanding cancer molecular basis. Recurrent deregulation patterns observed in multiple cancer types are enriched for such driver events.
View Article and Find Full Text PDFCannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Am J Physiol Heart Circ Physiol
December 2007
Cannabidiol (CBD) is a major, nonpsychoactive Cannabis constituent with anti-inflammatory activity mediated by enhancing adenosine signaling. Inasmuch as adenosine receptors are promising pharmaceutical targets for ischemic heart diseases, we tested the effect of CBD on ischemic rat hearts. For the in vivo studies, the left anterior descending coronary artery was transiently ligated for 30 min, and the rats were treated for 7 days with CBD (5 mg/kg ip) or vehicle.
View Article and Find Full Text PDF